Universe Pharmaceuticals (UPC) Current Taxes (2020 - 2025)
Universe Pharmaceuticals (UPC) reported Current Taxes of $640.8 million for Q3 2025, down 37.25% on a YoY basis from $1.0 billion in Q3 2024, and down 37.25% sequentially from $1.0 billion in Q3 2024.
Universe Pharmaceuticals (UPC) Current Taxes (2020 - 2025) Analysis & Trends
Universe Pharmaceuticals (UPC) has 6 years of Current Taxes data on file, last reported at $640.8 million in Q3 2025.
- For the quarter ending Q3 2025, Current Taxes fell 37.25% year-over-year to $640.8 million; the trailing twelve-month figure through Sep 2025 stood at $640.8 million (down 37.25% YoY), and the FY2025 full-year result was $640.8 million, down 37.25% from the prior year.
- Current Taxes slipped to $640.8 million in Q3 2025, from $1.0 billion in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $1.0 billion in Q3 2024 to a low of $172374.0 in Q1 2024.
- A 5-year average of $208.3 million and a median of $828872.5 in 2022 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes sank 66.2% in 2023 and jumped 234784.92% in 2024, its largest moves.
- Tracing UPC's Current Taxes over 5 years: stood at $1.5 million in 2021, then tumbled by 54.25% to $694955.0 in 2022, then tumbled by 37.44% to $434758.0 in 2023, then jumped by 234784.92% to $1.0 billion in 2024, then plunged by 37.25% to $640.8 million in 2025.
- Business Quant data shows UPC's Current Taxes at $640.8 million in Q3 2025, $1.0 billion in Q3 2024, and $172374.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 640.78 Mn |
| Sep 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 172,374.00 |
| Sep 30, 2023 | 434,758.00 |
| Mar 31, 2023 | 325,389.00 |
| Sep 30, 2022 | 694,955.00 |
| Mar 31, 2022 | 962,790.00 |
| Sep 30, 2021 | 1.52 Mn |
| Sep 30, 2020 | 118,986.00 |